Biotechnology: Pharmaceutical Preparations

Business UpdateMay 13, 2026, 07:02 AM

Opus Genetics to Present at RBC Global Healthcare Conference

AI Summary

Opus Genetics, Inc., a clinical-stage biopharmaceutical company, announced that its management will present at the RBC Capital Markets 2026 Global Healthcare Conference. The presentation is scheduled for Tuesday, May 19, 2026, at 11:00 a.m. ET, with a live and archived webcast accessible via the company's investor relations website. Opus Genetics focuses on developing gene therapies for inherited retinal diseases.

Key Highlights

Opus Genetics management to present at the RBC Capital Markets 2026 Global Healthcare Conference.
Presentation scheduled for Tuesday, May 19, 2026, at 11:00 a.m. ET.
A webcast link will be available on the company's Investors section: Events.

View SEC Filing

IRD

Biotechnology: Pharmaceutical Preparations

Opus Genetics, Inc.

Price Impact